Kv.ae butted.rno; Lisbet

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kv.ae butted.rno; Lisbet.The latest application filed is for "new catecholamine prodrugs for use in the treatment of parkinson's disease".

Company Profile

0.4.7

Kv.ae butted.rno; Lisbet - Valby DK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
New Catecholamine Prodrugs For Use In The Treatment Of Parkinson's Disease App 20220257623 - Jensen; Klaus Gjervig ; et al.	2022-08-18
Process For The Manufacture Of (2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(((4ar,10ar)-7-hydroxy-1-propyl-1,2,3- ,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2h-pyran-2-ca- Rboxylic Acid App 20220185839 - Juhl; Martin ; et al.	2022-06-16
Solid Forms Of (2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(((4ar,10ar)-7-hydroxy-1-propyl-1,2,3- ,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2h-pyran-2-ca- Rboxylic Acid App 20220024962 - Jensen; Klaus Gjervig ; et al.	2022-01-27
Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3- ,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-ca- rboxylic acid Grant 11,130,775 - Jensen , et al. September 28, 2	2021-09-28
Catecholamine prodrugs for use in the treatment of Parkinson's disease Grant 11,110,110 - Jensen , et al. September 7, 2	2021-09-07
Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-- 2H-pyran-2-carboxylic acid Grant 11,104,697 - Juhl , et al. August 31, 2	2021-08-31
Solid Forms Of (2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(((4ar,10ar)-7-hydroxy-1-propyl-1,2,3- ,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2h-pyran-2-ca- Rboxylic Acid App 20200392176 - Jensen; Klaus Gjervig ; et al.	2020-12-17
A Process For The Manufacture Of (2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(((4ar,10ar)-7-hydroxy-1-propyl-1,2,3- ,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2h-pyran-2-ca- Rboxylic Acid App 20200369705 - Juhl; Martin ; et al.	2020-11-26
Catecholamine Prodrugs For Use In The Treatment Of Parkinson's Disease App 20200338102 - Jensen; Klaus Gjervig ; et al.	2020-10-29
Catecholamine prodrugs for use in the treatment of Parkinson's disease Grant 10,729,710 - Jensen , et al.	2020-08-04
Catecholamine Prodrugs For Use In The Treatment Of Parkinson's Disease App 20190160083 - Jensen; Klaus Gjervig ; et al.	2019-05-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.